ALZpath

ALZpath is a developer of innovative diagnostic solutions for Alzheimer's disease. The company will accelerate the analytical and clinical validation of ALZpathDx, a proprietary assay for quantifying phosphorylated tau217 (pTau217), which is a highly accurate diagnostic biomarker for Alzheimer's disease.